August 13, 2023 | Case Study | Featured
Return on Good helps Lumicell launch next stage of groundbreaking breast cancer treatment innovation funding
In 2023, nearly 2 million people in the United States will be diagnosed with cancer. Approximately 300,000 will be women with breast cancer, making it the most common cancer diagnosis. For Lumicell, a MedTech company based in Newton, Massachusetts, this is personal. The founders were profoundly impacted by cancer. So, they set out to create […]
Read Post